SIDE-CHAIN ASSISTED LIGATION
position the nucleophilic amine in a close proximity to the acyl
group.
1MEPVDPRLEP WKHPGSQPKT ACTNCYCKKC
CFHCQVCFIT KALGISYGRK KRRQRRRAPQ
GSQTHQVSLS KQPTSQSRGD PTGPKE86
SCAL is an efficient method for peptide ligation due to the
commercial availability of the template, easiness to couple to the
side-chain of amino acid and the facile removal of the auxiliary
without prior product isolation. The rate-limiting step in the SCAL
is S–N acyl transfer; hence, it is possible to perform ligations under
low peptide concentrations, which increases its potential in the
synthesis of proteins.
O
O
S
O
O
H
+
N
Tat 38-60
HN
NH
SR
N
O
H
Tat 63-86
HN
O
O
HS
Limitations
NH2
We attempted the total chemical synthesis of the regulatory
protein HIV-1 Tat (86 residues) assisted by SCAL [16]. As shown
in Scheme 1, SCAL was used to link the middle fragment, HIV-
1 Tat(37–60), to the C-terminal fragment, HIV-1 Tat(61–86).
The resultant ligation product was exposed to methoxylamine
to covert the N-terminal Thz to Cys [17] affording HIV-1
Tat(37–86). Subsequently, employing NCL between fragments
HIV-1 Tat(37–86) and HIV-1 Tat(1–36), the N-terminal fragment,
yielded the full-length protein with auxiliary. Although the
construction of the fragments using SCAL (60% isolated yield
for the ligation and Thz removal steps) and NCL (70% isolated) was
very successful, the removal of the auxiliary from the polypeptide
was not fully accomplished. This could be due to a specific
conformation that the polypeptide adopts under these conditions,
which could mask the ester bond from saponification. A possible
mean to overcome this issue is to use such an auxiliary that
would allow ligation at pH 7 and could be detached from the
side-chain through preferred intramolecular cyclization at basic
pH. For example, an auxiliary that is derived from pipecolic acid
would yield quinolizidone (fused bicyclic six-membered ring) in
contrary to the cyclohexane-derived auxiliary, which could yield a
less preferred seven–six fused bicyclic system. Another limitation
is formation of aspartimide by-products, in particular when Asp
is used to anchor the auxiliary, which could occur throughout
the ligation and/or during the auxiliary removal steps. However,
aspartimide formation is considerably reduced when the amino
acid subsequent to Asp is sterically hindered. In principle, the use
of backbone protection or cleavage of the ligation product with
HF would also eliminate this side reaction.
1. SCAL
2. Thz-Cys conversion
O
HN
HS
H2N
-Gly-Ser(Aux)-
Tat 38-60
Tat 63-86
NCL
Tat 1-36
O
S(CH2)2C(O)OMe
-Cys-
-Gly-Ser(Aux)-
Tat 63-86
Tat 1-36
Tat 38-60
Scheme 1. The use of SCAL in the synthesis of HIV-1 Tat.
Synthesis of 3
Compound 2 (1.10 g, 2.55 mmol) was added to a solution of
Fmoc-Asp-OAll (0.80 g, 2.04 mmol) with DIC (0.35 ml, 2.30 mmol)
and catalytic amount of DMAP in dry DCM (20 ml) at 0 ◦C. The
reaction mixture was stirred at room temperature for 12 h. The
organic solvent was concentrated and extracted with ethyl acetate
(3 × 20 ml). The combined organic layer was washed with brine,
dried over MgSO4, concentrated and purified using flash column
chromatography (hexane/ethyl acetate 3 : 1) to give 1.20 g of
3 in 72% yield. Rf 0.27 [EtOAc–Hex (1 : 2)]. 1H NMR (500 MHz,
CDCl3) δ 0.94–1.45 (m, 4H), 1.52–1.99 (m, 4H), 2.70–3.25 (m,
4H), 3.62–3.82 (m, 1H), 4.10–4.27 (m, 2H), 4.27–4.42 (m, 1H),
4.42–4.58 (m, 1H), 4.58–4.75 (m, 3H), 5.23 (d, J = 10.7 Hz, 1H),
5.31 (d, J = 17.1 Hz, 1H), 5.80–5.94 (m, 1H), 7.06–7.64 (m, 19H),
7.57–7.70 (m, 2H), 7.76 (d, J = 7.4 Hz, 2H); 13C NMR (125 MHz,
CDCl3) δ 23.7, 23.9, 24.1, 30.7, 30.7, 30.7 31.3, 36.1, 36.2, 37.0,
37.0, 47.0, 47.1, 50.2, 50.6, 51.7, 52.2, 66.2, 66.4, 67.3, 67.4, 67.8,
67.9, 75.5, 75.8, 118.7, 118.8, 119.9, 125.2, 125.3, 127.0, 127.6,
127.9, 128.1, 129.5, 131.4, 131.5, 141.2, 143.8, 144.0, 155.9, 156.2,
168.2, 168.3, 170.1, 170.2, 170.6; MALDI-TOF (matrix: α-Cyano-4-
hydroxycinnamic acid): calcd. for C49H48N2O7S.Na+ [M + Na]+:
831.31 (monoisotope); C49H48N2O7S.K+ [M +K]+ (monoisotope):
847.42, found: 831.45, 847.40.
Experimental Procedure
Synthesis of Building Block 4
Synthesis of 2
Compound 1 (1.00 g, 6.38 mmol) was added to a solution of S-
trityl-2-mercaptoacetic acid (2.13 g, 6.38 mmol) with HBTU (2.53 g,
6.66 mmol) and DIEA (3.70 ml, 21.05 mmol) in dry DMF (15 ml). The
reaction mixture was stirred at room temperature for overnight,
diluted with ethyl acetate (40 ml) and washed with water and
brine. The organic layer was dried over MgSO4, concentrated and
purified over flash column chromatography (CHCl3/MeOH 20 : 1),
to give 2 (1.30 g) in 50% yield. Rf 0.73 [CHCl3 –MeOH (10 : 1)];
1H NMR (500 MHz, CDCl3) δ 0.92–1.35 (m, 4H), 1.55–1.75 (m,
3H), 1.9 (m, 1H), 2.79 (s, 2H), 3.09–3.20 (m, 2H), 3.28–3.38 (m,
1H), 6.07 (d, J = 6.8 Hz, 1H), 7.18–7.35 (m, 9H), 7.35–7.43 (m,
6H); 13C NMR (125 MHz, CDCl3) δ 23.8, 24.3, 30.9, 34.0, 35.9, 55.9,
68.0, 74.8, 127.1, 128.1, 129.4, 143.9, 170.0; MALDI-TOF (matrix: α-
Cyano-4-hydroxycinnamic acid): calcd. for C27H29NO2S.Na+, [M
+ Na]+: 454.18 (monoisotope); C27H29NO2S.K+ [M + K]+: 470.29
(monoisotope), found: 454.20, 470.16.
Synthesis of 4
Compound 3 (1.20 g, 1.50 mmol) was dissolved in THF (25 ml);
N-methylaniline (1.58 ml, 15.00 mmol) and Pd(PPh3)4 (0.17 g,
0.15 mmol) were added subsequently. The reaction mixture
was stirred at room temperature for 1 h. After removing the
solvent under reduced pressure, the residue was subjected to
column chromatography (MeOH/CH3Cl 20 : 1) to give 4 in 90%
yield (1.03 g). Rf 0.55 [CHCl3 –MeOH (10 : 1)]; H NMR (500 MHz,
CDCl3) δ 1.14–1.64 (m, 8H), 2.76–3.24 (m, 4H), 3.79–3.95 (m,
1H), 4.12–4.24 (m, 1H), 4.24–4.38 (m, 2H), 4.55–4.69 (m, 1H),
1
c
J. Pept. Sci. 2011; 17: 252–255 Copyright ꢀ 2011 European Peptide Society and John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci